FirstSight
Colorectal Cancer Screening and Prevention (Adenoma Detection)
NAActive
Key Facts
Indication
Colorectal Cancer Screening and Prevention (Adenoma Detection)
Phase
NA
Status
Active
Company
About CellMax Life
CellMax Life is a private diagnostics company founded in 2014, headquartered in Sunnyvale, California. It has developed a proprietary circulating epithelial cell capture platform, the CMx Bio-Mimetic platform, to detect precancerous and cancerous cells from a single blood draw. The company's lead product is FirstSight, a blood test for colorectal cancer screening aimed at detecting adenomas to enable prevention. It is positioned to address a significant gap in current non-invasive screening methods, which largely miss precancerous lesions.
View full company profile